Farther Finance Advisors’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Farther Finance Advisors’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-77	Closed	–	–	4230
2024 Q3	$0	Hold	77	–	–	﹤0.01%	4176
2024 Q2	$0	Buy	+77	New	+$1.14K	﹤0.01%	3973

Other funds holding MACK

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Farther Finance Advisors's MACK Position: Q4 2024 in Review

Farther Finance Advisors sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q4 2024, closing a stake of 77 shares.

Farther Finance Advisors first reported a position in MACK in Q2 2024 and held it in 2 quarters. The position peaked at $0 in Q3 2024. 2 funds tracked by Wall St. Rank hold MACK as of Q4 2024.

Farther Finance Advisors reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q4 2024 after selling out during the quarter.
Farther Finance Advisors sold 77 Merrimack Pharmaceuticals, Inc. shares in Q4 2024.
Farther Finance Advisors first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2024 and held it in 2 quarters.
Farther Finance Advisors's Merrimack Pharmaceuticals, Inc. position peaked at $0 in Q3 2024.
2 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q4 2024.

Based on Farther Finance Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.